text.skipToContent text.skipToNavigation

LGC Standards partners with PRIMACYT to improve access to hepatocytes for drug discovery research

Date:15 February 2011

LGC Standards is delighted to announce the addition of the PRIMACYT range of in-vitro products and services to its portfolio of life science research and drug discovery products. PRIMACYT currently offers hepatocyte cells to the drug discovery research community throughout Europe and the partnership with LGC Standards will facilitate a wider distribution of these cells and allow greater access to these important in-vitro models.

The drug development community recognises the need for improved in-vitro modelling systems and the collaboration between LGC - which holds the designated role as the UK's National Measurement Institute for chemical and bioanalytical measurement - and highly innovative companies such as PRIMACYT provides an ideal platform from which to develop new and more effective in-vitro systems and to facilitate their distribution.

Elizabeth Jordain, Managing Director of LGC Standards commented: ?We are delighted to add the PRIMACYT in-vitro products and services to our drug discovery products and services portfolio. The application and development of improved in-vitro systems as predictors of in-vivo response is a key area of focus for our ADMETox business and we believe the partnership with PRIMACYT creates an ideal opportunity for our two companies to work together to develop improved systems for in-vitro analysis. We expect that the PRIMACYT collaboration will offer opportunities to expand both the range of products available in the PRIMACYT portfolio and to develop new distribution channels for these important model systems for the drug discovery and development community.?

Dieter Runge, Managing Director at PRIMACYT said, ?We have seen significant increase in the demand for fresh hepatocytes to support in-vitro research and our partnership with LGC Standards offers an ideal platform from which to implement our product development and expanded distribution initiatives.?


- Ends -



Notes to editors

About LGC Standards
LGC Standards (www.lgcstandards.com) provides products and services to improve measurement and quality control within the laboratory, and is part of LGC, whose LGC Science & Technology Division acts as the UK National Measurement Institute for chemical and bioanalytical measurements. LGC Standards supplies over 100,000 products, including reference materials, pharmaceutical impurity reference standards (produced under ISO Guide 34 accreditation), biological standards and reagents, and proficiency testing. LGC Standards is headquartered in Teddington, Middlesex, UK. Its global centre for excellence in proficiency testing is located in Bury (Greater Manchester). LGC Standards has offices in France, Germany, Italy, Poland, Spain, Sweden, China, Russia, United Arab Emirates and the UK, a joint venture presence in India, and representatives in Brazil, Bulgaria, Czech Republic, Finland, Hungary, Ireland, the Netherlands, Romania, Turkey and the US.

About LGC
LGC (www.lgc.co.uk) is an international science-based company and market leader in analytical, forensic and diagnostic services and reference standards. LGC operates in a variety of markets which underpin the safety, health and security of the public and the regulation of industry, for both public and private sector clients.

LGC operates internationally through four divisions - LGC Forensics, LGC Genomics, LGC Standards and LGC Science & Technology. The latter includes specialist laboratories delivering contracts for the Department for Business, Innovation and Skills (BIS) and supports LGC's designated role as the UK's National Measurement Institute for chemical and bioanalytical measurement.

Our operations are extensively accredited to international quality standards such as ISO 17025. With headquarters in Teddington, South West London, the LGC Group employs ca 1,400 staff in 29 laboratories and centres globally. Privatised in 1996 and now majority-owned by funds managed by Bridgepoint, LGC was founded almost 170 years ago as the Laboratory of the Government Chemist - a statutory function maintained by LGC today.

About PRIMACYT
PRIMACYT Cell Culture Technology GmbH, located in the technology and business park in Schwerin, provides services in the area of in-vitro technologies for pharmaceutical and biotech industry. Human and animal hepatocytes are offered as biosensoric assay systems for pharmacologic-toxicological analyses of drugs and for analysis of chemicals and environmental substances.

With HEPAC2, the human hepatocyte cell culture system developed by PRIMACYT, clinical functional liver parameters in patients should be better predetermined than by animal studies. Since 2006 PRIMACYT offers studies in compliance with GLP, a quality control system demanded from international administration authorities for accreditation of newly developed drugs.



For further information contact:
Amanda Russell
Marketing Manager
LGC Standards
Queens Road
Teddington
Middlesex
TW11 0LY
UK
Tel: +44 (0)20 8943 7412
Fax: +44 (0)20 8943 7009
Email: amanda.russell@lgcstandards.com
www.lgcstandards.com

Sales and reader enquiries contact:
Jeffrey Anthony
LGC Standards
Queens Road
Teddington
Middlesex
TW11 0LY
UK
Tel: +44 (0)20 8943 8480
Fax: +44 (0)20 8943 7554
Email: cell@lgcstandards.com
www.lgcstandards.com

Gavin Dallas
Press & Communications Officer
LGC
Queens Road
Teddington
Middlesex
TW11 0LY
UK
Tel: +44 (0)20 8943 8491
Fax: +44 (0)20 8943 2767
Email: gavin.dallas@lgc.co.uk
www.lgc.co.uk

Advanced-Search.jpg

Advanced
search

Refine your
search

null

Online Ordering made easy

null

Sign up to our email newsletter

null

Catalogues

Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.